Invitrogen Corp. has created a new business unit in cell therapy. The field of cell therapy offers potential for new, novel therapies in fields such as wound care, neurological and immune disorders, and cardiovascular diseases, according to the company. The new Cell Therapy Systems business will be responsible for integrating relevant technologies — including Dynal magnetic beads for cell isolation, Gibco cell expansion media and Molecular Probes cell characterization tools — to meet the needs o...